These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8593012)

  • 1. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria.
    Zhai L; Blom J; Chen M; Christensen SB; Kharazmi A
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2742-8. PubMed ID: 8593012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
    Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
    J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.
    Chen M; Zhai L; Christensen SB; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2023-9. PubMed ID: 11408218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
    Chen M; Christensen SB; Blom J; Lemmich E; Nadelmann L; Fich K; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2550-6. PubMed ID: 8109916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.
    Chen M; Christensen SB; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1339-44. PubMed ID: 8092835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro leishmanicidal activity of naturally occurring chalcones.
    Kayser O; Kiderlen AF
    Phytother Res; 2001 Mar; 15(2):148-52. PubMed ID: 11268116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
    Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
    Chen M; Theander TG; Christensen SB; Hviid L; Zhai L; Kharazmi A
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1470-5. PubMed ID: 7979274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity.
    Hermoso A; Jiménez IA; Mamani ZA; Bazzocchi IL; Piñero JE; Ravelo AG; Valladares B
    Bioorg Med Chem; 2003 Sep; 11(18):3975-80. PubMed ID: 12927858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.
    Chen M; Brøgger Christensen S; Zhai L; Rasmussen MH; Theander TG; Frøkjaer S; Steffansen B; Davidsen J; Kharazmi A
    J Infect Dis; 1997 Nov; 176(5):1327-33. PubMed ID: 9359735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcones identify cTXNPx as a potential antileishmanial drug target.
    Escrivani DO; Charlton RL; Caruso MB; Burle-Caldas GA; Borsodi MPG; Zingali RB; Arruda-Costa N; Palmeira-Mello MV; de Jesus JB; Souza AMT; Abrahim-Vieira B; Freitag-Pohl S; Pohl E; Denny PW; Rossi-Bergmann B; Steel PG
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009951. PubMed ID: 34780470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain.
    Mi-Ichi F; Miyadera H; Kobayashi T; Takamiya S; Waki S; Iwata S; Shibata S; Kita K
    Ann N Y Acad Sci; 2005 Nov; 1056():46-54. PubMed ID: 16387676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural Investigation of
    Shokri A; Fakhar M; Emami S; Gill P; Akhtari J
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):246-255. PubMed ID: 30227826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major.
    Shokri A; Emami S; Fakhar M; Teshnizi SH; Keighobadi M
    Acta Trop; 2017 Mar; 167():73-78. PubMed ID: 28017860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of antileishmanial and antimalarial chalcones.
    Liu M; Wilairat P; Croft SL; Tan AL; Go ML
    Bioorg Med Chem; 2003 Jul; 11(13):2729-38. PubMed ID: 12788347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of chalcone analogues with increased antileishmanial activity.
    Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
    Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.